|
1
|
Su A, Zhao W, Wu W, Wei T, Ruan M, Li Z
and Zhu J: The association of preoperative thyroid-stimulating
hormone level and the risk of differentiated thyroid cancer in
patients with thyroid nodules: A systematic review and
meta-analysis. Am J Surg. 220:634–641. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Shao W, Kuhn C, Mayr D, Ditsch N,
Kailuweit M, Wolf V, Harbeck N, Mahner S, Jeschke U, Cavaillès V
and Sixou S: Cytoplasmic and nuclear forms of thyroid hormone
receptor β1 are inversely associated with survival in primary
breast cancer. Int J Mol Sci. 21(330)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Qiu K, Xie Q, Jiang S and Lin T: Silencing
of DJ-1 reduces proliferation, invasion, and migration of papillary
thyroid cancer cells in vitro, probably by increase of PTEN
expression. Int J Clin Exp Pathol. 12:2046–2055. 2019.PubMed/NCBI
|
|
4
|
Alghamdi M, Alkhamis WH, Jamjoom D,
Al-Nafisah G, Tahir A and Abdouelhoda M: Expanding the phenotype
and the genotype of Stromme syndrome: A novel variant of the CENPF
gene and literature review. Eur J Med Genet.
63(103844)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Fowler KJ, Saffery R, Irvine DV, Trowell
HE and Choo KH: Mouse centromere protein F (Cenpf) gene maps to the
distal region of chromosome 1 by interspecific backcross analysis.
Cytogenet Cell Genet. 82:180–181. 1998.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ozkinay F, Atik T, Isik E, Gormez Z,
Sagiroglu M, Sahin OA, Corduk N and Onay H: A further family of
Stromme syndrome carrying CENPF mutation. Am J Med Genet A.
173:1668–1672. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Waters AM, Asfahani R, Carroll P, Bicknell
L, Lescai F, Bright A, Chanudet E, Brooks A, Christou-Savina S,
Osman G, et al: The kinetochore protein, CENPF, is mutated in human
ciliopathy and microcephaly phenotypes. J Med Genet. 52:147–156.
2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhou CJ, Wang XY, Han Z, Wang DH, Ma YZ
and Liang CG: Loss of CENPF leads to developmental failure in mouse
embryos. Cell Cycle. 18:2784–2799. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Toralova T, Susor A, Nemcova L, Kepkova K
and Kanka J: Silencing CENPF in bovine preimplantation embryo
induces arrest at 8-cell stage. Reproduction. 138:783–791.
2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Shi J, Zhang P, Liu L, Min X and Xiao Y:
Weighted gene coexpression network analysis identifies a new
biomarker of CENPF for prediction disease prognosis and progression
in nonmuscle invasive bladder cancer. Mol Genet Genomic Med.
7(e982)2019.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Kim HE, Kim DG, Lee KJ, Son JG, Song MY,
Park YM, Kim JJ, Cho SW, Chi SG, Cheong HS, et al: Frequent
amplification of CENPF, GMNN and CDK13 genes in hepatocellular
carcinomas. PLoS One. 7(e43223)2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Pooley RD, Moynihan KL, Soukoulis V, Reddy
S, Francis R, Lo C, Ma LJ and Bader DM: Murine CENPF interacts with
syntaxin 4 in the regulation of vesicular transport. J Cell Sci.
121:3413–3421. 2008.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chen EB, Qin X, Peng K, Li Q, Tang C, Wei
YC, Yu S, Gan L and Liu TS: HnRNPR-CCNB1/CENPF axis contributes to
gastric cancer proliferation and metastasis. Aging (Albany NY).
11:7473–7491. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Göbel C, Özden C, Schroeder C, Hube-Magg
C, Kluth M, Möller-Koop C, Neubauer E, Hinsch A, Jacobsen F, Simon
R, et al: Upregulation of centromere protein F is linked to
aggressive prostate cancers. Cancer Manag Res. 10:5491–5504.
2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Li R, Wang X, Zhao X, Zhang X, Chen H, Ma
Y and Liu Y: Centromere protein F and Forkhead box M1 correlation
with prognosis of non-small cell lung cancer. Oncol Lett.
19:1368–1374. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Shahid M, Kim M, Lee MY, Yeon A, You S,
Kim HL and Kim J: Downregulation of CENPF remodels prostate cancer
cells and alters cellular metabolism. Proteomics.
19(e1900038)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Aytes A, Mitrofanova A, Lefebvre C,
Alvarez MJ, Castillo-Martin M, Zheng T, Eastham JA, Gopalan A,
Pienta KJ, Shen MM, et al: Cross-species regulatory network
analysis identifies a synergistic interaction between FOXM1 and
CENPF that drives prostate cancer malignancy. Cancer Cell.
25:638–651. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Shahid M, Lee MY, Piplani H, Andres AM,
Zhou B, Yeon A, Kim M, Kim HL and Kim J: Centromere protein F
(CENPF), a microtubule binding protein, modulates cancer metabolism
by regulating pyruvate kinase M2 phosphorylation signaling. Cell
Cycle. 17:2802–2818. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sun J, Huang J, Lan J, Zhou K, Gao Y, Song
Z, Deng Y, Liu L, Dong Y and Liu X: Overexpression of CENPF
correlates with poor prognosis and tumor bone metastasis in breast
cancer. Cancer Cell Int. 19(264)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Mariniello RM, Orlandella FM, Stefano AE,
Iervolino PLC, Smaldone G, Luciano N, Cervone N, Munciguerra F,
Esposito S, Mirabelli P and Salvatore G: The TUSC2 tumour
suppressor inhibits the malignant phenotype of human thyroid cancer
cells via SMAC/DIABLO Protein. Int J Mol Sci.
21(702)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Moreno I, Hirsch D, Duskin-Bitan H,
Diker-Cohen T, Shimon I and Robenshtok E: Response to therapy
assessment in intermediate-risk thyroid cancer patients-is rhTSH
stimulation required? Thyroid. 30:863–870. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yang Y, Zhao Z, Xie CW and Zhao Y:
Dual-targeting liposome modified by glutamic hexapeptide and folic
acid for bone metastatic breast cancer. Chem Phys Lipids.
228(104882)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhao Z, Zhao Y, Xie CW, Chen CQ, Lin D,
Wang S, Lin D, Cui X, Guo Z and Zhou J: Dual-active targeting
liposomes drug delivery system for bone metastatic breast cancer:
Synthesis and biological evaluation. Chem Phys Lipids.
223(104785)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Qiu ZL, Shen CT, Sun ZK, Song HJ, Zhang GQ
and Luo QY: Lung metastases from papillary thyroid cancer with
persistently negative thyroglobulin and elevated thyroglobulin
Antibody levels during radioactive iodine treatment and follow-up:
Long-term outcomes and prognostic indicators. Front Endocrinol
(Lausanne). 10(903)2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lin SC, Kao CY, Lee HJ, Creighton CJ,
Ittmann MM, Tsai SJ, Tsai SY and Tsai MJ: Dysregulation of
miRNAs-COUP-TFII-FOXM1-CENPF axis contributes to the metastasis of
prostate cancer. Nat Commun. 7(11418)2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Lokody I: Signalling: FOXM1 and CENPF:
Co-pilots driving prostate cancer. Nat Rev Cancer. 14:450–451.
2014.PubMed/NCBI View
Article : Google Scholar
|
|
28
|
Mahmoud AD, Ballantyne MD, Miscianinov V,
Pinel K, Hung J, Scanlon JP, Iyinikkel J, Kaczynski J, Tavares AS,
Bradshaw AC, et al: The human-specific and smooth muscle
cell-enriched LncRNA SMILR promotes proliferation by regulating
mitotic CENPF mRNA and drives cell-cycle progression which can be
targeted to limit vascular remodeling. Circ Res. 125:535–551.
2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Dai Y, Liu L, Zeng T, Zhu YH, Li J, Chen
L, Li Y, Yuan YF, Ma S and Guan XY: Characterization of the
oncogenic function of centromere protein F in hepatocellular
carcinoma. Biochem Biophys Res Commun. 436:711–718. 2013.PubMed/NCBI View Article : Google Scholar
|
